Author

David-Étienne Tremblay

Institution: CHU Sainte-Justine Research Center

Observed institutions: CHU Sainte-Justine Research Center, Université de Montréal

ORCID: 0000-0002-9286-8434

Observed ORCID: 0000-0002-9286-8434

OpenAlex ID: A5019513610

Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes

2022 · Tiffany Habelrih, David-Étienne Tremblay, et al. · American Journal of Obstetrics and Gynecology · 22

The Succinate Receptor SUCNR1 Resides at the Endoplasmic Reticulum and Relocates to the Plasma Membrane in Hypoxic Conditions

2022 · Melanie Sanchez, David Hamel, et al. · Cells · 21

IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients

2023 · Covida Mootoosamy, Maria Kondyli, et al. · Pharmacogenomics · 5

Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols

2021 · Maria Kondyli, David-Étienne Tremblay, et al. · Leukemia Research · 3

Works count: 4

Citation count: 51

H-index: 3

I10-index: 2